| PRKCG |
PRKCG, PKCG: Protein kinase C gamma type |
TSC2 |
TSC2, TSC4: Tuberin |
8.927 |
Evidence |
|
| ATP1A1 |
ATP1A1: Sodium/potassium-transporting ATPase subunit alpha-1 precursor |
MAP2K2 |
MAP2K2, MEK2, MKK2, PRKMK2: Dual specificity mitogen-activated protein kinase ki |
8.927 |
Evidence |
|
| TP53 |
TP53, P53: Cellular tumor antigen p53 |
DUSP6 |
DUSP6, MKP3, PYST1: Dual specificity protein phosphatase 6 |
8.927 |
Evidence |
|
| TP53 |
TP53, P53: Cellular tumor antigen p53 |
DUSP16 |
DUSP16, KIAA1700, MKP7: Dual specificity protein phosphatase 16 |
8.927 |
Evidence |
|
| FOS |
FOS, G0S7: Proto-oncogene protein c-fos |
SMAD1 |
SMAD1, BSP1, MADH1, MADR1: Mothers against decapentaplegic homolog 1 |
8.927 |
Evidence |
|
| EGFR |
EGFR, ERBB1: Epidermal growth factor receptor precursor |
PRKCQ |
PRKCQ, PRKCT: Protein kinase C theta type |
8.927 |
Evidence |
|
| EGFR |
EGFR, ERBB1: Epidermal growth factor receptor precursor |
CD82 |
CD82, KAI1, SAR2, ST6, TSPAN27: CD82 antigen |
8.927 |
Evidence |
|
| EGFR |
EGFR, ERBB1: Epidermal growth factor receptor precursor |
GNAT1 |
GNAT1, GNATR: Guanine nucleotide-binding protein G(t), alpha-1 subunit |
8.927 |
Evidence |
|
| CHEK2 |
CHEK2, CHK2, RAD53: Serine/threonine-protein kinase Chk2 |
MYST4 |
MYST4, KIAA0383, MORF, MOZ2: Histone acetyltransferase MYST4 |
8.927 |
Evidence |
|
| CHEK2 |
CHEK2, CHK2, RAD53: Serine/threonine-protein kinase Chk2 |
GTF2B |
GTF2B, TF2B, TFIIB: Transcription initiation factor IIB |
8.927 |
Evidence |
|
| CHEK2 |
CHEK2, CHK2, RAD53: Serine/threonine-protein kinase Chk2 |
BRCA1 |
BRCA1, RNF53: Breast cancer type 1 susceptibility protein |
8.927 |
Evidence |
|
| CXorf9 |
IPI00004504 |
PARD6A |
PARD6A, PAR6A: Partitioning defective 6 homolog alpha |
8.927 |
Evidence |
|
| SYNCRIP |
SYNCRIP, HNRPQ, NSAP1: Heterogeneous nuclear ribonucleoprotein Q |
DDX20 |
DDX20, DP103, GEMIN3: Probable ATP-dependent RNA helicase DDX20 |
8.927 |
Evidence |
|
| WASPIP |
IPI00552369 |
ELMO1 |
IPI00219532 |
8.927 |
Evidence |
|
| WASPIP |
IPI00552369 |
CDC2L5 |
CDC2L5, CDC2L, CHED, KIAA1791: Cell division cycle 2-like protein kinase 5 |
8.927 |
Evidence |
|
| MAP3K7 |
MAP3K7, TAK1: Mitogen-activated protein kinase kinase kinase 7 |
MAPK1 |
MAPK1, ERK2, PRKM1, PRKM2: Mitogen-activated protein kinase 1 |
8.927 |
Evidence |
|
| MAP3K7 |
MAP3K7, TAK1: Mitogen-activated protein kinase kinase kinase 7 |
STAM2 |
STAM2: Signal transducing adapter molecule 2 |
8.927 |
Evidence |
|
| PDPK1 |
PDPK1, PDK1: 3-phosphoinositide-dependent protein kinase 1 |
TLN1 |
TLN1: Uncharacterized protein TLN1 |
8.927 |
Evidence |
|
| PDPK1 |
PDPK1, PDK1: 3-phosphoinositide-dependent protein kinase 1 |
HSF1 |
HSF1, HSTF1: Heat shock factor protein 1 |
8.927 |
Evidence |
|
| PDPK1 |
PDPK1, PDK1: 3-phosphoinositide-dependent protein kinase 1 |
JUN |
JUN: Transcription factor AP-1 |
8.927 |
Evidence |
|
| MAFG |
MAFG: Transcription factor MafG |
STAT1 |
STAT1: Signal transducer and activator of transcription 1-alpha/beta |
8.927 |
Evidence |
|
| HGS |
HGS, HRS: Hepatocyte growth factor-regulated tyrosine kinase substrate |
SMAD1 |
SMAD1, BSP1, MADH1, MADR1: Mothers against decapentaplegic homolog 1 |
8.927 |
Evidence |
|
| HGS |
HGS, HRS: Hepatocyte growth factor-regulated tyrosine kinase substrate |
LATS1 |
LATS1, WARTS: Serine/threonine-protein kinase LATS1 |
8.927 |
Evidence |
|
| PAK7 |
PAK7, KIAA1264, PAK5: Serine/threonine-protein kinase PAK 7 |
SLA |
SLA, SLAP, SLAP1: SRC-like-adapter |
8.922 |
Evidence |
|
| PAK7 |
PAK7, KIAA1264, PAK5: Serine/threonine-protein kinase PAK 7 |
BLNK |
BLNK, BASH, SLP65: B-cell linker protein |
8.922 |
Evidence |
|